Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC) Skin Test Phase II
CTR20232022Phase 2Completed
- Sponsor
- Chengdu Keen Biotechnology
- Start
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of C-Tb in Tuberculosis (TB), sponsored by Chengdu Keen Biotechnology. Started Jul 2023; status: completed.
02
Drugs
C-Tb
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on CTR20232022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232022.